Published in Lab Law Weekly, June 10th, 2005
Recently, NanoLogix, Inc. (formerly Infectech, Inc.) signed a feasibility study with the Department of Environmental Science and Engineering of Gannon University in Erie, Pennsylvania, to develop a bioreactor which utilizes NanoLogix's patented bacterial culturing methods in order to produce hydrogen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.